Hims & Hers Health (HIMS) Competitors $27.13 +0.32 (+1.19%) Closing price 04/11/2025 03:59 PM EasternExtended Trading$27.22 +0.09 (+0.31%) As of 04/11/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HIMS vs. NTRA, FMS, OPCH, GH, RDNT, BTSG, SHC, SGRY, PRVA, and CONShould you be buying Hims & Hers Health stock or one of its competitors? The main competitors of Hims & Hers Health include Natera (NTRA), Fresenius Medical Care (FMS), Option Care Health (OPCH), Guardant Health (GH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Privia Health Group (PRVA), and Concentra Group Holdings Parent (CON). These companies are all part of the "healthcare" industry. Hims & Hers Health vs. Natera Fresenius Medical Care Option Care Health Guardant Health RadNet BrightSpring Health Services Sotera Health Surgery Partners Privia Health Group Concentra Group Holdings Parent Natera (NASDAQ:NTRA) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, community ranking, earnings, profitability, valuation, dividends and institutional ownership. Which has more risk & volatility, NTRA or HIMS? Natera has a beta of 1.8, indicating that its stock price is 80% more volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 1.65, indicating that its stock price is 65% more volatile than the S&P 500. Do insiders and institutionals hold more shares of NTRA or HIMS? 99.9% of Natera shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 7.6% of Natera shares are held by company insiders. Comparatively, 17.7% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Do analysts recommend NTRA or HIMS? Natera currently has a consensus target price of $175.76, suggesting a potential upside of 18.73%. Hims & Hers Health has a consensus target price of $38.25, suggesting a potential upside of 40.99%. Given Hims & Hers Health's higher possible upside, analysts plainly believe Hims & Hers Health is more favorable than Natera.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Natera 0 Sell rating(s) 0 Hold rating(s) 16 Buy rating(s) 0 Strong Buy rating(s) 3.00Hims & Hers Health 2 Sell rating(s) 7 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.21 Is NTRA or HIMS more profitable? Hims & Hers Health has a net margin of 8.19% compared to Natera's net margin of -14.01%. Hims & Hers Health's return on equity of 10.97% beat Natera's return on equity.Company Net Margins Return on Equity Return on Assets Natera-14.01% -26.23% -14.27% Hims & Hers Health 8.19%10.97%8.29% Does the MarketBeat Community prefer NTRA or HIMS? Natera received 448 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 68.96% of users gave Natera an outperform vote while only 36.44% of users gave Hims & Hers Health an outperform vote. CompanyUnderperformOutperformNateraOutperform Votes49168.96% Underperform Votes22131.04% Hims & Hers HealthOutperform Votes4336.44% Underperform Votes7563.56% Which has better valuation and earnings, NTRA or HIMS? Hims & Hers Health has lower revenue, but higher earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNatera$1.70B11.79-$434.80M-$1.53-96.76Hims & Hers Health$1.48B4.08-$23.55M$0.5450.24 Does the media prefer NTRA or HIMS? In the previous week, Hims & Hers Health had 7 more articles in the media than Natera. MarketBeat recorded 31 mentions for Hims & Hers Health and 24 mentions for Natera. Natera's average media sentiment score of 1.39 beat Hims & Hers Health's score of 0.93 indicating that Natera is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Natera 17 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 19 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive SummaryNatera and Hims & Hers Health tied by winning 9 of the 18 factors compared between the two stocks. Remove Ads Get Hims & Hers Health News Delivered to You Automatically Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HIMS vs. The Competition Export to ExcelMetricHims & Hers HealthOffices & clinics of medical doctors IndustryMedical SectorNYSE ExchangeMarket Cap$6.03B$970.42M$5.25B$18.30BDividend YieldN/AN/A5.34%4.13%P/E Ratio61.6615.8521.3630.71Price / Sales4.081.05366.3225.88Price / CashN/A36.0138.1517.55Price / Book16.857.856.284.25Net Income-$23.55M-$52.07M$3.19B$1.02B7 Day Performance4.63%5.35%0.66%1.34%1 Month Performance-20.21%8.88%-11.10%-7.29%1 Year Performance94.20%-17.76%4.51%-1.36% Hims & Hers Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HIMSHims & Hers Health3.5808 of 5 stars$27.13+1.2%$38.25+41.0%+86.1%$6.03B$1.48B61.66650Analyst ForecastInsider TradeNews CoverageNTRANatera3.0271 of 5 stars$138.65+3.6%$178.12+28.5%+53.1%$18.77B$1.70B-78.893,020Analyst ForecastPositive NewsFMSFresenius Medical Care2.8362 of 5 stars$23.34-2.5%$25.30+8.4%+26.6%$13.70B$19.34B19.29123,200Positive NewsGap DownOPCHOption Care Health3.092 of 5 stars$33.51-0.1%$33.00-1.5%+0.4%$5.50B$5.00B28.125,600News CoveragePositive NewsGHGuardant Health4.0077 of 5 stars$42.14+3.8%$48.95+16.2%+134.0%$5.19B$739.02M-11.821,790Analyst UpgradeNews CoverageRDNTRadNet3.8169 of 5 stars$48.96+0.5%$73.25+49.6%+8.5%$3.64B$1.83B-701.938,970Analyst ForecastNews CoveragePositive NewsBTSGBrightSpring Health Services2.5848 of 5 stars$17.47+1.9%$21.67+24.0%+63.9%$3.05B$11.27B-67.0335,000News CoverageGap DownSHCSotera Health2.315 of 5 stars$10.27-0.7%$16.00+55.9%-8.0%$2.92B$1.10B41.213,000Analyst ForecastPositive NewsSGRYSurgery Partners2.7861 of 5 stars$21.06-0.2%$36.63+73.9%-19.1%$2.69B$3.11B-43.9113,500Positive NewsGap DownPRVAPrivia Health Group3.3031 of 5 stars$21.84-0.6%$26.67+22.1%+31.4%$2.63B$1.74B218.32810Analyst ForecastNews CoveragePositive NewsGap DownCONConcentra Group Holdings ParentN/A$20.39-1.1%$28.50+39.8%N/A$2.60B$1.90B13.5011,000Positive NewsGap Down Remove Ads Related Companies and Tools Related Companies NTRA Competitors FMS Competitors OPCH Competitors GH Competitors RDNT Competitors BTSG Competitors SHC Competitors SGRY Competitors PRVA Competitors CON Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:HIMS) was last updated on 4/12/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThis almost killed Elon Musk (chilling details emerge)Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredWARNING to All American InvestorsForget the headlines about the "trade war." This is where a real military showdown between China and the U....Behind the Markets | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HIMS Stock Free HIMS Stock Alerts